Topics and Faculty

• Carotid Stenting in High-Risk Patients
Christopher White, MD
Chairman, Department of Cardiology
Ochsner Clinic Foundation
New Orleans, LA

• Critique of Carotid Stenting Data
Seemant Chaturvedi,
MD, FAHA, FAAN
Professor of Neurology
Wayne State University School
of Medicine
Director, WSU/DMC Stroke Program
Detroit, MI

• Ongoing Trials in Conventional Risk Patients
Larry Wechsler, MD
Director, UPMC Stroke Institute
Vice-Chair, Clinical Affairs
Department of Neurology
Professor of Neurology
University of Pittsburgh Medical School
Pittsburgh, PA

• Role of Intensive Medical Management
J. David Spence,
MD, MBA, BA, FRCPC, FAHA
Stroke Prevention & Atherosclerosis
Research Centre
Siebens-Drake/Robarts Research
Institute
London, Ontario, Canada


•Carotid Artery Stenting Case Studies
Kenneth Rosenfield, MD
Director of Cardiac and Vascular Invasive Services
Division of Cardiology
Massachusetts General Hospital

---

This activity is sponsored by the North American Center for Continuing Medical Education.

---

This activity is supported by an educational grant from Abbott Vascular.

---

Target Audience:

Neurologists

---

Learning Objectives:

Upon completion of this educational activity, participants should be able to:
• Compare current medical management of carotid stenosis to earlier trials
• Utilize multimodality medical management of carotid stenosis in the treatment of patients
• Discuss effectiveness of intensive medical therapy, including Mediterranean diet, smoking cessation, blood pressure control, lipid-lowering therapy, and vitamin therapy in regressing carotid plaque and reducing risk in patients with carotid stenosis
• Review use of transcranial Doppler microemboli for risk stratification in asymptomatic carotid stenosis and the decline in microemboli with intensive medical therapy
• Describe the features that make CEA high risk
• Compare the advantages and disadvantages of stents versus CEA in high surgical risk patients
• Discuss the design and preliminary results of conventional risk studies comparing CEA and CAS
• Compare the differences between conventional risk and high risk patients for CAS.

---

Accreditation:

MD/DO: This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

---

Disclosure Policy:

Faculty and all others who have the ability to control the content of continuing medical education activities sponsored by NACCME are expected to disclose whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s). It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations. Full faculty disclosures will be made in the course syllabus book.